COVID-19, diabetes mellitus and ACE2: The conundrum
Top Cited Papers
- 26 March 2020
- journal article
- editorial
- Published by Elsevier BV in Diabetes Research and Clinical Practice
- Vol. 162, 108132
- https://doi.org/10.1016/j.diabres.2020.108132
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetesDiabetologia, 2017
- Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional studyThe Lancet Diabetes & Endocrinology, 2017
- The Effect of Short-Term Hyperglycemia on the Innate Immune SystemThe American Journal of the Medical Sciences, 2016
- Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes RatsEndocrinology, 2015
- Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infectionsNature Communications, 2014
- Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011–2012: Hospital-based Influenza Morbidity & Mortality (HIMM) surveillanceJournal of Infection and Chemotherapy, 2014
- Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and DiseaseInternational Journal of Peptides, 2012
- The “Metabolic Memory”: Is More Than Just Tight Glucose Control Necessary to Prevent Diabetic Complications?Journal of Clinical Endocrinology & Metabolism, 2009
- Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARSDiabetic Medicine, 2006
- Immune dysfunction in patients with diabetes mellitus (DM)FEMS Immunology & Medical Microbiology, 1999